Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
R. Douglas Pratt
Observed names:
R Douglas Pratt,
R. D. Pratt,
R. DOUGLAS PRATT,
R. Pratt,
Rdouglas Pratt
Institutions:
Center for Biologics Evaluation and Research,
United States Food and Drug Administration
Observed institutions:
Center for Biologics Evaluation and Research,
United States Food and Drug Administration,
University of California San Diego
OpenAlex ID:
A5111908153
An Assessment of Thimerosal Use in Childhood Vaccines
2001
·
Leslie K. Ball
, Robert Ball
, et al.
·
PEDIATRICS
·
339
Virologic Markers of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid of Infected Children
1996
·
R. D. Pratt
, S. Nichols
, et al.
·
The Journal of Infectious Diseases
·
56
Regulatory considerations in development of vaccines to prevent disease caused by Chikungunya virus
2017
·
Sixun Yang
, Doran Fink
, et al.
·
Vaccine
·
25
Toxicity of antiretroviral agents
1997
·
Kimberly A. Struble
, R. Douglas Pratt
, et al.
·
The American Journal of Medicine
·
23
Thiomersal in Vaccines
2001
·
Cjohn Clements
, Leslie K. Ball
, et al.
·
Drug Safety
·
15
Clinical Development Strategies and Considerations for Zika Vaccine Licensure
2017
·
Marion F Gruber
, Karen M Farizo
, et al.
·
The Journal of Infectious Diseases
·
12
PDF
False-positive Results With Hiv Elisa Kits
1986
·
P. Nuttall
, R. Pratt
, et al.
·
The Lancet
·
12
Rapidly recurrent enteroviral meningitis in non‐immunocompromised infants caused by different viral strains
1995
·
Nectar Aintablian
, R. Douglas Pratt
, et al.
·
Journal of Medical Virology
·
5
Pediatric human immunodeficiency virus infection in a low seroprevalence area
1993
·
R. DOUGLAS PRATT
, RITA HATCH
, et al.
·
The Pediatric Infectious Disease Journal
·
4
Pneumococcal Disease
2012
·
R. Douglas Pratt
·
Elsevier eBooks
Show more works
View as search
Works count:
10
Citation count:
491
H-index:
7
I10-index:
7
Year
Topic
Type
